Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending November 28, 2012. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 768,000 Ordinary Shares of 25 pence each.
- Purchase Date: November 28, 2012.
- Price Range: Highest price paid was 1,340.5 pence per share; lowest price paid was 1,329.5 pence per share.
- Treasury Holdings: 490,140,427 shares held in Treasury (9.08% of total issued share capital).
- Voting Rights: Including unsettled purchases, Treasury shares represent 9.98% of total voting rights.
- Shares in Issue: 4,909,815,903 shares (excluding Treasury shares).
Material Changes
The primary material change reported is the reduction of outstanding share capital through the cancellation of 768,000 repurchased shares. Consequently, the total number of shares in issue (excluding Treasury) is now 4,909,815,903. The filing does not provide comparative data against prior periods for financial performance.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a compliance disclosure confirming adherence to the Financial Services Authority's Disclosure and Transparency Rules regarding share repurchases.
Investor Verification Checklist
- Verify the total number of shares in issue (4,909,815,903) for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the updated Treasury share count (490,140,427) and its impact on total voting rights (9.98%).
- Note that the repurchased shares are cancelled, permanently reducing the company's share capital.
- Recognize that this filing does not contain operational or financial performance data for the period.